CVS Health stock is trading -12.74% below its average target price of $65.48 after dropping -1.2% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $59.0 to $81.0 per share.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.4%. The stock's short ratio is 1.93. The company's insiders own 0.11% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 81.3%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 9% | 116,117,490 | $6,634,953,307 |
| 2024-03-31 | Blackrock Inc. | 7% | 87,101,436 | $4,976,975,999 |
| 2024-03-31 | State Street Corporation | 4% | 55,004,275 | $3,142,944,239 |
| 2024-03-31 | Capital World Investors | 3% | 43,776,874 | $2,501,410,553 |
| 2024-03-31 | Dodge & Cox Inc | 3% | 41,012,543 | $2,343,456,681 |
| 2024-03-31 | Capital International Investors | 3% | 37,917,923 | $2,166,630,097 |
| 2024-03-31 | FMR, LLC | 3% | 34,423,281 | $1,966,946,255 |
| 2024-03-31 | Morgan Stanley | 2% | 29,039,992 | $1,659,345,125 |
| 2024-03-31 | Geode Capital Management, LLC | 2% | 25,382,075 | $1,450,331,750 |
| 2024-03-31 | Bank of America Corporation | 1% | 16,159,874 | $923,375,190 |
